Covered recipient · General Payments record
ANTHONY CONLIN TORRES
Allopathic & Osteopathic Physicians Psychiatry & Neurology Neurology
General Payments · PY2018
$690.91
- Reported across 16 records
- CMS publication 2026-01-23
Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.
How these totals are calculated
- The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
- General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
- Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
- Methodology & Data — sourcing, labeling, and limitations.
By nature of payment
PY2018 · sorted by reported total
| Nature of payment | Amount | Records |
|---|---|---|
| Food and Beverage | $642.56 | 14 |
| Education | $48.35 | 2 |
By paying entity
PY2018 · sorted by reported total
| Paying entity | Amount | Records |
|---|---|---|
| EMD Serono, Inc. | $274.91 | 4 |
| CHIESI USA, INC. | $263.02 | 3 |
| UCB, Inc. | $30.73 | 2 |
| EISAI INC. | $23.66 | 1 |
| MERZ NORTH AMERICA, INC. | $22.30 | 1 |
| Biogen, Inc. | $18.73 | 1 |
| Mallinckrodt LLC | $17.63 | 1 |
| Janssen Pharmaceuticals, Inc | $14.43 | 1 |
| Kedrion Biopharma Inc. | $12.84 | 1 |
| UPSHER-SMITH LABORATORIES LLC | $12.66 | 1 |
By program year
All program years on this page · sorted by year
| Program year | Amount | Records |
|---|---|---|
| PY2018 | $690.91 | 16 |
Payment records · PY2018 (16)
Sorted by paying entity, then date · as published by CMS
| Paying entity | Amount | Date | Nature of payment | Dispute status | Published | Record ID | Source |
|---|---|---|---|---|---|---|---|
| Biogen, Inc. | $18.73 | 05/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 553679329 | CMS |
| Chiesi USA, Inc. | $134.94 | 01/17/2018 | Food and Beverage | Undisputed | 01/23/2026 | 611013695 | CMS |
| Chiesi USA, Inc. | $126.93 | 01/25/2018 | Food and Beverage | Undisputed | 01/23/2026 | 611014057 | CMS |
| Chiesi USA, Inc. | $1.15 | 10/30/2018 | Education | Undisputed | 01/23/2026 | 611013783 | CMS |
| Eisai Inc. | $23.66 | 02/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 603781441 | CMS |
| EMD Serono, Inc. | $17.72 | 02/26/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615017212 | CMS |
| EMD Serono, Inc. | $100.00 | 03/20/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615025721 | CMS |
| EMD Serono, Inc. | $47.20 | 03/20/2018 | Education | Undisputed | 01/23/2026 | 717638471 | CMS |
| EMD Serono, Inc. | $109.99 | 04/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | 615030589 | CMS |
| Janssen Pharmaceuticals, Inc | $14.43 | 02/07/2018 | Food and Beverage | Undisputed | 01/23/2026 | 548983729 | CMS |
| Kedrion Biopharma Inc. | $12.84 | 03/12/2018 | Food and Beverage | Undisputed | 01/23/2026 | 535540531 | CMS |
| Mallinckrodt LLC | $17.63 | 02/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 617770693 | CMS |
| Merz North America, Inc. | $22.30 | 03/28/2018 | Food and Beverage | Undisputed | 01/23/2026 | 613803139 | CMS |
| UCB, Inc. | $15.34 | 04/09/2018 | Food and Beverage | Undisputed | 01/23/2026 | 546116679 | CMS |
| UCB, Inc. | $15.39 | 06/13/2018 | Food and Beverage | Undisputed | 01/23/2026 | 546116309 | CMS |
| Upsher-Smith Laboratories LLC | $12.66 | 04/16/2018 | Food and Beverage | Undisputed | 01/23/2026 | 538639997 | CMS |
Source & provenance
- Dataset
- CMS Open Payments — General Payments
- Publisher of source data
- Centers for Medicare & Medicaid Services
- CMS publication date
- 2026-01-23
- Program years on this page
- 2018
- Source files
- Dataset page · Bulk file · PY2018
- Generated from
- OP_DTL_GNRL_PGYR2018_P01232026_01102026.csv
One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.
Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.